DaVita HealthCare Partners reaches a level of strong resistance. This level could counteract the upward trend in the short term.

From fundamental viewpoint, shares have reached the analyst's consensus which should limit the appreciation potential. Moreover, analysts have also revised downward their EPS estimates during the year which could lead to some profit taking in the short run.

Technically, shares have reached the strong USD 78.05 resistance and could encourage investors to take some profit. Moreover, prices don't get a real orientation as shown by flat daily moving averages. Therefore a return toward the USD 75.05 support could happen in coming sessions.

The most offensive investor can benefit from the technical configuration to take a short position. The objective will be fixed near to the USD 75.05 support. The stop loss will be set above USD 78.05.